- 1. Secure our presence in the generics business.
- 2. Achieve a stronger position in the hyperuricemia market, centered on Uralyt.
- 3. Contribute to society through proprietary developments toward drug discovery.
The goal of the Chemiphar Group is to make a difference in society by providing pharmaceutical drugs and health-related services to help people become and remain healthy.
August 30, 2024 | |
---|---|
July 31, 2024 | Summary of consolidated financial results for the first quarter of FY2024. (pdf, 173KB) |
July 31, 2024 | |
June 29, 2024 | Notice of the 92nd Ordinary General Meeting of Shareholders. (PDF, 375KB) |
May 13, 2024 | Summary of Consolidated Financial Results for the Fiscal Year 2023. (pdf, 204KB) |
---|---|
May 13, 2024 | |
May 07, 2024 | |
January 31, 2024 | Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year 2023. (pdf, 152KB) |
January 31, 2024 | |
October 31, 2023 | Summary of Consolidated Financial Results for the Second Quarter of Fiscal Year 2023. (pdf, 157KB) |